Skip to main content

Table 1 Baseline characteristics of the patients

From: Genetic diagnosis and outcomes of intracytoplasmic sperm injection in South Chinese patients with congenital bilateral aplasia of the vas deferens

Characteristic

 

No-CBAVD-OA

(n = 112)

CBAVD

(n = 42)

P value

Male age (years)

 

33(30 ~ 36)

31.5(30 ~ 33)

0.062

Types of infertility (n)

Primary infertility

29

42

 

Secondary infertility

83

  

Etiology (n)

Epididymitis

54

  

Post-epididymovasostomy

22

  

Post-vasovasostomy

9

  

Genital tuberculosis

3

  

vasectomy

11

  

Inguinal or pelvic surgeries

5

  

trauma

8

  

Semen parameters

Abstinence period

5(4 ~ 5.25)

5(3.25 ~ 5)

0.256

Volume(mL)

3.2(2.7 ~ 4.0)

0.9(0.5 ~ 1.0)

 < 0.000001

pH

7.6(7.4 ~ 7.8)

6.9(6.6 ~ 7.2)

 < 0.000001

Sex hormones

FSH(IU/L)

5.9(2.9 ~ 8.1)

5.5(3.9 ~ 8.1)

0.5

LH(IU/L)

5.0(3.3 ~ 6.4)

4.7(3.5 ~ 5.8)

0.57

T(nmol/L)

16.3(10.8 ~ 21.6)

15.8(13.6 ~ 21.5)

0.386

E2(pmol/L)

99.6(72.8 ~ 121.0)

97.4(68.4 ~ 111.8)

0.218

PRL(mIU/L)

174.5(117.4 ~ 235.1)

204.7(121.1 ~ 255.2)

0.31

  1. Comparison of baseline characteristics between patients with Congenital Bilateral Aplasia of the Vas Deferens (CBAVD, n = 42) and obstructive azoospermia without CBAVD (No-CBAVD-OA, n = 112)
  2. Continuous variables were presented as medians (first quartile-third quartile) and compared using the Mann–Whitney U rank-sum test
  3. Categorical variables were presented as % (n/N) and compared using the chi-squared test
  4. P value < 0.05 was considered statistically significant
  5. CBAVD Congenital Bilateral Aplasia of the Vas Deferens, OA Obstructive azoospermia, FSH Follicle‑stimulating hormone, LH Luteinizing hormone, E2 Estradiol, T Testosterone, PRL Prolactin